Serotype | N | Prevalence | 95% CI of the prevalence | % Biotype II |
---|---|---|---|---|
9/11 | 197 | 39.24 | 34.96–43.53 | 5.29 |
2 | 141 | 28.09 | 24.14–32.03 | 1.42 |
13 | 49 | 9.76 | 7.16–12.37 | 70.83 |
5 | 44 | 8.76 | 6.28–11.25 | 0 |
8 | 31 | 6.18 | 4.06–8.29 | 3.23 |
6 | 12 | 2.39 | 1.05–3.73 | 0 |
7 | 11 | 2.19 | 0.91–3.48 | 9.09 |
3 | 4 | 0.8 | 0.02–1.58 | 25.0 |
4 | 3 | 0.6 | 0–1.27 | 0 |
14 | 3 | 0.6 | 0–1.27 | 100 |
10 | 2 | 0.4 | 0–0.95 | 0 |
15 | 2 | 0.4 | 0–0.95 | 100 |
1 | 1 | 0.2 | 0–0.59 | 0 |
12 | 1 | 0.2 | 0–0.59 | 0 |
18 | 1 | 0.2 | 0–0.59 | 0 |